Rapid Micro Biosystems (RPID) Competitors

$1.71 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$1.75 +0.04 (+2.28%)

As of 06/18/2026 07:27 PM Eastern

RPID vs. SENS, NAUT, INTT, QSI, and QTRX

Should you buy Rapid Micro Biosystems stock or one of its competitors? MarketBeat compares Rapid Micro Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rapid Micro Biosystems include Senseonics Holdings, Inc. Common Stock (SENS), Nautilus Biotechnology (NAUT), inTEST (INTT), Quantum-Si (QSI), and Quanterix (QTRX). These companies are all part of the "measuring and control equipment" industry.

How does Rapid Micro Biosystems compare to Senseonics Holdings, Inc. Common Stock?

Rapid Micro Biosystems (NASDAQ:RPID) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

In the previous week, Senseonics Holdings, Inc. Common Stock's average media sentiment score of 1.49 beat Rapid Micro Biosystems' score of 0.00 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Rapid Micro Biosystems	Neutral
Senseonics Holdings, Inc. Common Stock	Positive

Rapid Micro Biosystems presently has a consensus price target of $6.00, indicating a potential upside of 250.88%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.00, indicating a potential upside of 152.23%. Given Rapid Micro Biosystems' higher possible upside, equities research analysts plainly believe Rapid Micro Biosystems is more favorable than Senseonics Holdings, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Rapid Micro Biosystems has higher earnings, but lower revenue than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.35	-$47.12M	-$1.12	N/A
Senseonics Holdings, Inc. Common Stock	$35.26M	7.99	-$69.11M	-$2.00	N/A

Rapid Micro Biosystems has a net margin of -145.81% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Senseonics Holdings, Inc. Common Stock's return on equity of -129.97% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
Senseonics Holdings, Inc. Common Stock	-213.87%	-129.97%	-67.14%

Rapid Micro Biosystems has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Senseonics Holdings, Inc. Common Stock beats Rapid Micro Biosystems on 8 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

50.7% of Nautilus Biotechnology shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 41.1% of Nautilus Biotechnology shares are held by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Nautilus Biotechnology had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 1 mentions for Nautilus Biotechnology and 0 mentions for Rapid Micro Biosystems. Nautilus Biotechnology's average media sentiment score of 0.00 equaled Rapid Micro Biosystems'average media sentiment score.

Company	Overall Sentiment
Nautilus Biotechnology	Neutral
Rapid Micro Biosystems	Neutral

Rapid Micro Biosystems has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nautilus Biotechnology	N/A	N/A	-$59M	-$0.46	N/A
Rapid Micro Biosystems	$33.59M	2.35	-$47.12M	-$1.12	N/A

Nautilus Biotechnology currently has a consensus price target of $4.00, suggesting a potential upside of 75.44%. Rapid Micro Biosystems has a consensus price target of $6.00, suggesting a potential upside of 250.88%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than Nautilus Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nautilus Biotechnology	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Nautilus Biotechnology has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market.

Nautilus Biotechnology has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -145.81%. Nautilus Biotechnology's return on equity of -35.04% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nautilus Biotechnology	N/A	-35.04%	-29.16%
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%

Summary

Rapid Micro Biosystems beats Nautilus Biotechnology on 8 of the 14 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to inTEST?

Rapid Micro Biosystems (NASDAQ:RPID) and inTEST (NYSE:INTT) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

inTEST has a net margin of 2.33% compared to Rapid Micro Biosystems' net margin of -145.81%. inTEST's return on equity of 5.31% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
inTEST	2.33%	5.31%	3.42%

Rapid Micro Biosystems has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, inTEST has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market.

52.6% of Rapid Micro Biosystems shares are owned by institutional investors. Comparatively, 63.2% of inTEST shares are owned by institutional investors. 12.7% of Rapid Micro Biosystems shares are owned by insiders. Comparatively, 5.2% of inTEST shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Rapid Micro Biosystems currently has a consensus target price of $6.00, indicating a potential upside of 250.88%. inTEST has a consensus target price of $19.00, indicating a potential upside of 1.06%. Given Rapid Micro Biosystems' higher possible upside, analysts plainly believe Rapid Micro Biosystems is more favorable than inTEST.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

inTEST has higher revenue and earnings than Rapid Micro Biosystems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.35	-$47.12M	-$1.12	N/A
inTEST	$121.07M	1.95	$9.34M	$0.04	470.00

In the previous week, Rapid Micro Biosystems' average media sentiment score of 0.00 equaled inTEST'saverage media sentiment score.

Company	Overall Sentiment
Rapid Micro Biosystems	Neutral
inTEST	Neutral

Summary

inTEST beats Rapid Micro Biosystems on 10 of the 14 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Quantum-Si?

Quantum-Si (NASDAQ:QSI) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Rapid Micro Biosystems has a net margin of -145.81% compared to Quantum-Si's net margin of -5,605.88%. Quantum-Si's return on equity of -47.35% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-5,605.88%	-47.35%	-42.66%
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%

Rapid Micro Biosystems has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	89.16	-$101.34M	-$0.51	N/A
Rapid Micro Biosystems	$33.59M	2.35	-$47.12M	-$1.12	N/A

Quantum-Si has a beta of 3.18, indicating that its stock price is 218% more volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

Quantum-Si currently has a consensus price target of $1.00, indicating a potential upside of 0.10%. Rapid Micro Biosystems has a consensus price target of $6.00, indicating a potential upside of 250.88%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Quantum-Si.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

39.9% of Quantum-Si shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 22.0% of Quantum-Si shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Quantum-Si had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 1 mentions for Quantum-Si and 0 mentions for Rapid Micro Biosystems. Quantum-Si's average media sentiment score of 0.00 equaled Rapid Micro Biosystems'average media sentiment score.

Company	Overall Sentiment
Quantum-Si	Neutral
Rapid Micro Biosystems	Neutral

Summary

Rapid Micro Biosystems beats Quantum-Si on 8 of the 15 factors compared between the two stocks.

How does Rapid Micro Biosystems compare to Quanterix?

Rapid Micro Biosystems (NASDAQ:RPID) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Rapid Micro Biosystems has higher earnings, but lower revenue than Quanterix. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	2.35	-$47.12M	-$1.12	N/A
Quanterix	$138.90M	1.15	-$107.15M	-$2.36	N/A

In the previous week, Quanterix had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 1 mentions for Quanterix and 0 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 0.00 equaled Quanterix'saverage media sentiment score.

Company	Overall Sentiment
Rapid Micro Biosystems	Neutral
Quanterix	Neutral

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 86.5% of Quanterix shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 1.5% of Quanterix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Rapid Micro Biosystems has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Quanterix has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market.

Rapid Micro Biosystems currently has a consensus target price of $6.00, suggesting a potential upside of 250.88%. Quanterix has a consensus target price of $4.00, suggesting a potential upside of 17.99%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, equities analysts plainly believe Rapid Micro Biosystems is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Quanterix has a net margin of -71.86% compared to Rapid Micro Biosystems' net margin of -145.81%. Quanterix's return on equity of -23.92% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.81%	-131.52%	-67.48%
Quanterix	-71.86%	-23.92%	-17.66%

Summary

Rapid Micro Biosystems beats Quanterix on 8 of the 14 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RPID vs. The Competition

Export

Metric	Rapid Micro Biosystems	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$78.95M	$7.11B	$6.42B	$12.59B
Dividend Yield	N/A	1.25%	2.68%	5.81%
P/E Ratio	-1.53	47.59	24.56	24.44
Price / Sales	2.35	86.83	553.91	122.27
Price / Cash	N/A	25.13	45.07	55.09
Price / Book	2.28	7.18	10.80	6.58
Net Income	-$47.12M	$159.20M	$3.57B	$337.17M
7 Day Performance	-2.84%	-0.49%	0.72%	0.83%
1 Month Performance	-17.39%	1.29%	0.41%	2.25%
1 Year Performance	-48.49%	7.51%	29.34%	36.14%

Rapid Micro Biosystems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RPID Rapid Micro Biosystems	2.3234 of 5 stars	$1.71 flat	$6.00 +250.9%	-48.5%	$78.95M	$33.59M	N/A	200
SENS Senseonics Holdings, Inc. Common Stock	4.0203 of 5 stars	$7.23 -0.1%	$17.00 +135.1%	N/A	$302.65M	$35.26M	N/A	90	Positive News
NAUT Nautilus Biotechnology	2.3241 of 5 stars	$2.17 -3.6%	$4.00 +84.3%	+219.0%	$285.93M	N/A	N/A	130	News Coverage Gap Down
INTT inTEST	0.2599 of 5 stars	$17.67 -4.7%	$19.00 +7.5%	+172.9%	$222.02M	$121.07M	76.83	320
QSI Quantum-Si	1.1531 of 5 stars	$0.95 -3.5%	$1.00 +4.8%	-42.3%	$215.26M	$2.44M	N/A	150	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RPID) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rapid Micro Biosystems (RPID) Competitors

RPID vs. SENS, NAUT, INTT, QSI, and QTRX

How does Rapid Micro Biosystems compare to Senseonics Holdings, Inc. Common Stock?

Summary

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Summary

How does Rapid Micro Biosystems compare to inTEST?

Summary

How does Rapid Micro Biosystems compare to Quantum-Si?

Summary

How does Rapid Micro Biosystems compare to Quanterix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rapid Micro Biosystems (RPID) Competitors

RPID vs. SENS, NAUT, INTT, QSI, and QTRX

How does Rapid Micro Biosystems compare to Senseonics Holdings, Inc. Common Stock?

Does the media refer more to RPID or SENS?

Do analysts recommend RPID or SENS?

Which has stronger valuation & earnings, RPID or SENS?

Is RPID or SENS more profitable?

Which has more risk and volatility, RPID or SENS?

Do insiders and institutionals have more ownership in RPID or SENS?

Summary

How does Rapid Micro Biosystems compare to Nautilus Biotechnology?

Do institutionals and insiders have more ownership in NAUT or RPID?

Does the media prefer NAUT or RPID?

Which has preferable earnings and valuation, NAUT or RPID?

Do analysts rate NAUT or RPID?

Which has more volatility and risk, NAUT or RPID?

Is NAUT or RPID more profitable?

Summary

How does Rapid Micro Biosystems compare to inTEST?

Is RPID or INTT more profitable?

Which has more risk & volatility, RPID or INTT?

Do institutionals & insiders believe in RPID or INTT?

Do analysts rate RPID or INTT?

Which has higher earnings and valuation, RPID or INTT?

Does the media refer more to RPID or INTT?

Summary

How does Rapid Micro Biosystems compare to Quantum-Si?

Is QSI or RPID more profitable?

Which has higher valuation & earnings, QSI or RPID?

Which has more risk and volatility, QSI or RPID?

Do analysts prefer QSI or RPID?

Do institutionals & insiders hold more shares of QSI or RPID?

Does the media prefer QSI or RPID?

Summary

How does Rapid Micro Biosystems compare to Quanterix?

Which has stronger valuation and earnings, RPID or QTRX?

Does the media favor RPID or QTRX?

Do institutionals and insiders have more ownership in RPID or QTRX?

Which has more volatility & risk, RPID or QTRX?

Do analysts recommend RPID or QTRX?

Is RPID or QTRX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID vs. The Competition

Rapid Micro Biosystems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools